Clinical Trials Directory

Trials / Terminated

TerminatedNCT01199991

Comparison of Xtreme CT and DXA Bone Densitometry

Status
Terminated
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Dual-energy x-ray absorptiometry (DXA) is currently the most widely used tool for determining bone density. However, most experts consider DXA an imperfect and intermediate technology. DXA is subject to artifact from arthritis and body composition, and also cannot account for geometric or material properties of bone which are also important components of bone strength. Xtreme CT (high-resolution peripheral quantitative computed tomography, HR-pQCT) is a new technology with dramatically improved spatial resolution. It is able to define bones' cortical and trabecular surfaces in a three-dimensional manner, and therefore provides information on bone microarchitecture as well as bone density. As such, it may provide new information about characteristics of bone strength. The purpose of this study is to compare Xtreme CT to DXA measurements of bone density, and also to generate a normative database of healthy young adults. This cross-sectional study involves a single visit where both Xtreme CT and DXA measurements will be obtained for a single time-point. This normative database will allow us to generate clinically relevant comparisons between the two imaging technologies.

Conditions

Timeline

Start date
2010-08-01
Primary completion
2018-06-29
Completion
2018-06-29
First posted
2010-09-13
Last updated
2019-03-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01199991. Inclusion in this directory is not an endorsement.

Comparison of Xtreme CT and DXA Bone Densitometry (NCT01199991) · Clinical Trials Directory